Skip to main content

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring. 

 Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth. 

Urgent Care Apps Market


The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030. 

 The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of this decade.

The COVID-19 pandemic has positively impacted the global urgent care apps market due to factors such as shift in preference from at-clinic to at-home virtual care, technological advancements in healthcare, and improving internet connectivity.

COVID-19 impact on urgent care market


BIS RESEARCH’S TAKE ON THE INDUSTRY

What is the addressable market size and forecast based on region? 

The North America region has one of the most technologically advanced healthcare systems globally. The various factors propelling the growth of the regional market include increasing smartphone adoption and the presence of established as well as emerging players in the market. 

In Europe, evolving regulatory landscape and the government’s measures to bolster data privacy are the primary reasons contributing to the growth of the regional market.

The emergence of 5G technology is one of the major factors driving the growth of the urgent care apps market in Asia-Pacific.

What are the key trends of the global urgent care apps market? 

 The key technological trends anticipated to have maximum influence on the global urgent care apps market during the forecast period 2021-2030 include artificial intelligence for personalized care, shift from physical care to telemedicine, remote patient monitoring ecosystems, increasing smartphone penetration, and focus on the entire patient journey beyond diagnosis. 

 In the short term, i.e., during 2021-2025, the key trends anticipated to impact the global urgent care apps market include the ongoing shift from physical care to telemedicine and remote patient monitoring. This is due to factors such as technological advancements in cellular communications, such as the growth of 4G and 5G and government initiatives to promote telemedicine. The growth is anticipated to be considered in growing economies such as China, India, Brazil, and Mexico.

 In the long term, i.e., during 2025-2030, the key trend expected to disrupt the global urgent care apps market is the shift toward telemedicine. The integration of AI in healthcare is anticipated due to the rising awareness about the technology, its potential to streamline healthcare processes and enable physicians to make better decisions.

Key Trends On Urgent Care App Market

     
    What are the market shares of key competitors in the global urgent care apps market? 

The global urgent care apps market is fragmented in nature, owing to the presence of various key companies. The companies offer a diverse product portfolio of mobile apps operating in a variety of areas such as pre-, post-, and in-hospital communication and collaboration, medication adherence, triaging communication, and consultation. North America and Europe currently represent the hub of technology innovation.      

Urgent Care App Market

           

RELATED MARKET REPORTS 



ABOUT BIS HEALTHCARE

 BIS healthcare vertical offers intelligence in the healthcare technology market for precision medicine, robotics and imaging, life sciences and biopharma, medical devices, digital health, and other emerging healthcare technologies, covering the entire industry spectrum. In the past eight years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating ‘Top 25 Voices’ in precision medicine on its InsightMonk platform for the past two years successfully.


                                                                                                                                                                        



 


Comments

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...

Global Liquid Biopsy Market is Projected to Reach $12,933 Million by 2030

 According to a new market intelligence report by BIS Research titled ‘Global Liquid Biopsy Market – Analysis and Forecast, 2020-2030’, The liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030 BIS Research Report: https://bisresearch.com/industry-report/global-liquid-biopsy-market.html   This growth has been primarily attributed to the rising number of cancer cases coupled up with the growing awareness pertaining to non-invasive detection approaches, the increasing adoption of inorganic growth strategies by key players in the market, and the increasing research funding from the leading organizations such as the U.S. National Institute of Health, globally. The market is expected to grow at a significant growth rate due to opportunities such as the introduction of informatics and technological innovations for a large customer base and increasing adoption of cancer and other disea...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...